What Is Injectable HIV PrEP? Clinicians’ Quick Guide

i

What Is Injectable HIV PrEP? Clinicians’ Quick Guide

Public Domain

August 2022
By Centers for Disease Control and Prevention (U.S.)
Series: Ending the HIV Epidemic

File Language:

English

Details

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

The US Food and Drug Administration (FDA) has approved one injectable pre-exposure prophylaxis

(PrEP) medication: cabotegravir (CAB) 600 mg (brand name Apretude®). CAB is a single antiretroviral drug given as an intramuscular injection every 2 months to prevent HIV.

In 2021, the US Preventive Services Task Force issued a graded recommendation to prescribe CAB for PrEP to adult patients who are at risk of getting HIV through sex (grade IA).

cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-injectable-hiv-prep.pdf
Subjects:

Anti-HIV Agents/therapeutic Use HIV Infections/prevention & Control Pre-Exposure Prophylaxis
Series:

Ending the HIV Epidemic ; Let's Stop HIV Together
Document Type:

Text
Genre:

Fact Sheet
Pages in Document:

4 unnumbered pages
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha-512:91043e4dded54b4d2fea38a48d75378a5f19b0a01145190bd8b653dcc9d3cb898883f5519b76dabbf6da3981e60a1b51c0bed56de8d54babc83dc0bc4c1f6d4e
Download URL:

https://stacks.cdc.gov/view/cdc/158767/cdc_158767_DS1.pdf
File Type:

[PDF - 966.18 KB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.